-7.49% for Injective — oversold signals fail to trigger reversal as downtrend persists

Traders Union
All News
Crypto News
Injective slides 7.49% to $4.02 today

Highlights

INJ is trading at $4.02, significantly below its MA-20 ($4.84), MA-50 ($4.86), and MA-200 ($9.40), signaling persistent multi-timeframe bearish pressure.
Momentum indicators including MACD, ADX, and oscillators such as RSI (34.26) and Stochastic RSI (0.00) all confirm oversold conditions amid strong sell-side dominance.
Expected five-day price range is $3.80–$4.40 with a less than 20% probability of a bounce, while further downside below $3.80 could trigger additional declines.

Oversold momentum readings as intraday volatility fuels bearish pressure

Momentum readings from MACD and ADX point to continued bearishness, suggesting sellers remain firmly in control. Most oscillators, including RSI (34.26), Stochastic RSI (0.00), and CCI (–115.46), indicate oversold conditions, reflecting potential exhaustion but not yet a reversal. Bull/Bear Power shows clear seller dominance, and the Awesome Oscillator aligns with the overall downtrend. A sizable gap down opened the session, with current losses reaching 7.49% and price trading near today’s low of $3.96, highlighting high intraday volatility and persistent sell-side pressure since the open. While oversold readings may hint at a possible pause or bounce, the prevailing daily momentum and intraday action both support the continuation of prevailing bearish sentiment.

Further declines favored as trend indicators reinforce bearish outlook

For the coming five trading days, the anticipated price range is adjusted to $3.80 – $4.40 to reflect typical volatility and keep the range near the current value. There is a very low probability (less than 20%) of a meaningful price increase, with a much greater likelihood of further downside as all weekly and daily trend indicators project continued weakness. The baseline scenario calls for sideways movement within the recent range. A bullish scenario would require a break above $4.40 towards $4.95, while further weakness below $3.80 could open the door for additional declines.

Viktoras Karapetjanc, expert at Traders Union, sees prevailing bearish momentum for Injective (INJ) with all major trend indicators pointing down. He notes the absence of macro or sentiment news as an additional factor keeping buying interest low. Despite deeply oversold conditions, Karapetjanc remains confident that further downside is likely unless a clear catalyst emerges. In his view, short-term stabilization could occur, but optimism is reserved for a confirmed break above resistance. "Until INJ closes above $4.40, I favor patiently waiting for a stronger reversal signal before considering long exposure."

Previously it was reported that Injective (INJ) trades well below its major moving averages, with all key intraday and momentum indicators—including MACD, RSI, Stochastic RSI, and CCI—aligning to confirm persistent bearish pressure and rising volatility. With sellers firmly in control and no clear support identified, the asset appears vulnerable to further downside or consolidation until a significant technical reversal occurs.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.